Executed by an interdisciplinary, world-class team with deep experience in RNA and structural biology, artificial intelligence, machine learning, genomics, engineering, and physics, we are THE RNA structure company.
Founder & CEO
Staff Scientist,
Machine Learning
Head of ML
Data Generation
Machine Learning
Engineer
Operations and
Compliance Specialist
Senior Scientist,
Computational
Chemistry
Strategy and Finance
Intern
Business Operations
Manager
Machine Learning
Engineer
Research Associate
Chief Scientific Officer
Head of
Business Development
Founding Scientist,
RNA Biology
Senior Scientist,
Computational Biology
Staff Scientist,
Chemistry
Screening Lead
Scientist, Computational
Structural Biology
Associate Scientist
Head of Machine Learning
& Founding Scientist
Head of People
Project Management
Lead
Senior Research
Associate
Machine Learning
Engineer
Ron Dror,
Computational Biology and Machine Learning
Professor of Computer Science, Stanford University
Leads research group that uses molecular simulation and machine learning to elucidate biomolecular structure, dynamics, and function.
Percy Carter,
Drug Discovery Leader and Biotech Executive
CSO of Blueprint Medicines and Board member of HiFiBiO Therapeutics
Previous scientific leadership roles at Fibrogen, Janssen, and BMS
Gene Yeo,
RNA Biology and RNA Therapeutics
Professor of Cellular and Molecular Medicine, UCSD
His research focuses on the importance of RNA processing and the roles that RNA binding proteins play in development and disease.
Nicholas Meanwell,
Drug Hunter and Medicinal Chemist
Former Scientific VP of Small Molecule Drug Discovery at Bristol-Myers Squibb
Advanced 33 clinical candidates over a 40-year career at BMS
Amanda Garner,
RNA Drug Discovery, Chemistry, and Biology
Associate Professor, Medicinal Chemistry, University of Michigan
Works to unlock the druggability of RNA by bridging chemistry and biology.